Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Oxford University Press
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/7623 |
Similar Items
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)
by: Miles, D., et al.
Published: (2013)
AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
by: Gianni, L., et al.
Published: (2013)
by: Gianni, L., et al.
Published: (2013)
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2010)
by: Miles, D., et al.
Published: (2010)
HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)
by: Chan, Arlene
Published: (2016)
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
by: Cinieri, S., et al.
Published: (2017)
by: Cinieri, S., et al.
Published: (2017)
Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)
by: Chan, Arlene, et al.
Published: (2009)
TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)
by: Chan, Arlene
Published: (2017)
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)
by: Dent, R., et al.
Published: (2013)
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2013)
by: Chan, Arlene, et al.
Published: (2013)
Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
by: Chan, Arlene, et al.
Published: (2012)
by: Chan, Arlene, et al.
Published: (2012)
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study
by: Hyams, D., et al.
Published: (2013)
by: Hyams, D., et al.
Published: (2013)
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)
by: Cameron, David, et al.
Published: (2013)
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
by: Bergh, J., et al.
Published: (2012)
by: Bergh, J., et al.
Published: (2012)
Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
by: Wolff, A., et al.
Published: (2013)
by: Wolff, A., et al.
Published: (2013)
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
by: Wolff, A., et al.
Published: (2013)
by: Wolff, A., et al.
Published: (2013)
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)
by: De Boer, R., et al.
Published: (2012)
Pigment epithelium-derived factor and
menopause in metastatic breast cancer
by: Brook, Naomi Louise
Published: (2022)
by: Brook, Naomi Louise
Published: (2022)
Glutamate regulation of Voltage-Gated Sodium Channels (VGSCS) in breast cancer cell lines of different metastatic potential
by: Azahar, Irfan Irsyad
Published: (2022)
by: Azahar, Irfan Irsyad
Published: (2022)
Studies towards low oxidation state taxanes
by: Sadia, Reema
Published: (2022)
by: Sadia, Reema
Published: (2022)
Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2014)
by: Chan, Arlene, et al.
Published: (2014)
Evaluation of fatty liver in breast cancer patients and its metastatic potential
by: Ahmad, Nor Hayati
Published: (2021)
by: Ahmad, Nor Hayati
Published: (2021)
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
by: Chan, Arlene, et al.
Published: (2012)
by: Chan, Arlene, et al.
Published: (2012)
Role of novel therapeutic agents in modulating invadopodia formation in metastatic breast cancer
by: Siti Nor Aini Harun,, et al.
Published: (2020)
by: Siti Nor Aini Harun,, et al.
Published: (2020)
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
by: Shin, E., et al.
Published: (2014)
by: Shin, E., et al.
Published: (2014)
An investigation of metastatic colorectal cancer
by: Asiri, Abutaleb
Published: (2018)
by: Asiri, Abutaleb
Published: (2018)
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)
by: Chan, Arlene
Published: (2017)
Treatment of MCF-7 and MDA-MB-231 human breast cancer cell lines with erythropoietin, doxorubicin and their combination
by: Radwan, Esam M.
Published: (2015)
by: Radwan, Esam M.
Published: (2015)
Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness
by: Chan, Arlene
Published: (2016)
by: Chan, Arlene
Published: (2016)
Synthetic chemistry and synthetic biology approaches to low oxidation state taxanes
by: Marsh, Benjamin J.
Published: (2017)
by: Marsh, Benjamin J.
Published: (2017)
Understanding factors associated with delay in seeking treatment among locally advanced and metastatic breast cancer in Hospital Raja Perempuan Zainab II
by: Karim, Mohd Firdaus A.
Published: (2020)
by: Karim, Mohd Firdaus A.
Published: (2020)
Investigation of Taxol biosynthetic genes for the production of novel taxanes in heterologous plant systems
by: Narraidoo, Nathalie
Published: (2011)
by: Narraidoo, Nathalie
Published: (2011)
Investigating the role of Cten in metastatic colorectal cancer
by: Thorpe, Hannah
Published: (2016)
by: Thorpe, Hannah
Published: (2016)
The study of relationship between cancer markers and age of patient in primary and metastatic paraffinized breast cancer tissue / Nur Azimah Osman
by: Osman, Nur Azimah
Published: (2009)
by: Osman, Nur Azimah
Published: (2009)
Microbiota profile of Malaysian kefir grain and anti-metastatic effects of kefir water in murine breast cancer cells
by: Zamberi, Nur Rizi
Published: (2016)
by: Zamberi, Nur Rizi
Published: (2016)
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
by: Alexander, Angela, et al.
Published: (2017)
by: Alexander, Angela, et al.
Published: (2017)
Cytotoxic effects of damnacanthal and damnacanthal-doxorubicin combination on human breast cancer cell line (MCF-7)
by: Abdul Aziz, Muhammad Yusran
Published: (2012)
by: Abdul Aziz, Muhammad Yusran
Published: (2012)
Investigation the role of CD24 in metastatic colorectal cancer
by: Alsulaiman, Abdullah
Published: (2018)
by: Alsulaiman, Abdullah
Published: (2018)
Molecular characterisation of the early metastatic phenotype in colorectal cancer
by: Sculthorpe, Declan
Published: (2024)
by: Sculthorpe, Declan
Published: (2024)
The current status of checkpoint inhibitors in metastatic bladder cancer
by: Fahmy Ahmed, Omar Ahmed, et al.
Published: (2016)
by: Fahmy Ahmed, Omar Ahmed, et al.
Published: (2016)
Optimising targeted antibodies for the treatment of metastatic solid tumours
by: Herbertson, Rebecca A.
Published: (2009)
by: Herbertson, Rebecca A.
Published: (2009)